Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

F Huemer; L. Weiss; P. Regitnig; T. Winder; Clemens Schmitt; Johannes Thaler; Ewald Wöll; Richard Greil

doi:10.1016/j.esmoop.2024.102973

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

F Huemer, L. Weiss, P. Regitnig, T. Winder, Clemens Schmitt, Johannes Thaler, Ewald Wöll, Richard Greil

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	102973
Number of pages	3
Journal	ESMO Open
DOIs	https://doi.org/10.1016/j.esmoop.2024.102973
Publication status	Published - Apr 2024

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.esmoop.2024.102973

Cite this

@article{82dbabab55d34f56825820643e0f446e,

title = "Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma",

author = "F Huemer and L. Weiss and P. Regitnig and T. Winder and Clemens Schmitt and Johannes Thaler and Ewald W{\"o}ll and Richard Greil",

year = "2024",

month = apr,

doi = "10.1016/j.esmoop.2024.102973",

language = "English",

journal = "ESMO Open",

}

TY - JOUR

T1 - Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

AU - Huemer, F

AU - Weiss, L.

AU - Regitnig, P.

AU - Winder, T.

AU - Schmitt, Clemens

AU - Thaler, Johannes

AU - Wöll, Ewald

AU - Greil, Richard

PY - 2024/4

Y1 - 2024/4

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC10966168/

U2 - 10.1016/j.esmoop.2024.102973

DO - 10.1016/j.esmoop.2024.102973

M3 - Article

JO - ESMO Open

JF - ESMO Open

M1 - 102973

ER -

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this